跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

32677

Supelco

鼠得克

PESTANAL®, analytical standard

别名:

3-(3-联苯基-1,2,3,4-四氢-1-萘基)-4-羟基-2H-1-苯并吡喃-2-酮, 3-(3-联苯基-1,2,3,4-四氢-1-萘基)-4-羟基香豆素

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C31H24O3
CAS号:
56073-07-5
分子量:
444.52
Beilstein:
8360065
EC 号:
259-978-4
MDL编号:
MFCD01632770
UNSPSC代码:
41116107
PubChem化学物质编号:
329754289
NACRES:
NA.24

等级

analytical standard

质量水平

100

产品线

PESTANAL®

保质期

limited shelf life, expiry date on the label

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

agriculture
environmental

包装形式

neat

SMILES字符串

OC1=C(C2CC(Cc3ccccc23)c4ccc(cc4)-c5ccccc5)C(=O)Oc6ccccc16

InChI

1S/C31H24O3/c32-30-26-12-6-7-13-28(26)34-31(33)29(30)27-19-24(18-23-10-4-5-11-25(23)27)22-16-14-21(15-17-22)20-8-2-1-3-9-20/h1-17,24,27,32H,18-19H2

InChI key

FVQITOLOYMWVFU-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

Difenacoum is a coumarin anticoagulant, which is developed as a rodenticide, in order to control warfarin‐resistant rodents.

应用

Difenacoum may be used as a reference standard in the determination of difenacoum in tissue samples using high performance liquid chromatography (HPLC).
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

法律信息

PESTANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 1 Dermal - Acute Tox. 1 Inhalation - Acute Tox. 1 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - STOT RE 1

靶器官

Blood

储存分类代码

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

法规信息

非剧毒-急性毒性1
危险化学品
农药列管产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL1265
BCCG1520
BCCD4919
BCBT5181

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

R Wallin
The Biochemical journal, 236(3), 685-693 (1986-06-15)
In the liver, it appears that there are two different pathways for vitamin K reduction. One pathway is irreversibly inhibited by coumarin anticoagulant drugs. The other pathway has been shown in the present study to be composed of enzymes that
M J Kelly et al.
Journal of chromatography, 620(1), 105-112 (1993-10-22)
A rapid and sensitive high-performance liquid chromatographic method for the analysis of cis and trans diastereomers of the anticoagulant rodenticide difenacoum has been described. The methodology demonstrates potential for the analysis of diastereomers of related 4-hydroxycoumarin anticoagulants. Separations were achieved
Field trials of second-generation anticoagulants against difenacoum-resistant Norway rat population.
Greaves HJ, et al.
Epidem. Inf., 89(2), 295-301 (1982)
J E Gill et al.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 104(1), 29-36 (1993-01-01)
1. A new test for identifying levels of difenacoum resistance in the Norway rat is described, based upon the differential physiological response to difenacoum administration. 2. This test is based on changes in blood clotting activity over 4 days, following
Stefan Endepols et al.
Pest management science, 69(3), 409-413 (2012-04-25)
Field studies guided by genetic monitoring of Vkorc1 need to be done to implicate mutations conclusively with rodent control problems due to the presence of animals resistant to anticoagulant rodenticides. Rodent control success in relation to Vkorc1 genotypes in house
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门